furosemide has been researched along with Tuberculosis, Meningeal in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Tuberculosis, Meningeal: A form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA. The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. (From Adams et al., Principles of Neurology, 6th ed, pp717-9)
Excerpt | Relevance | Reference |
---|---|---|
"Patients with non-communicating hydrocephalus received ventriculo-peritoneal shunts shortly after admission while communicating hydrocephalus was treated with oral acetazolamide (100 mg/kg/day) and furosemide (1 mg/kg/day) in 3-4 divided doses." | 1.31 | Long-term follow up of childhood tuberculous meningitis. ( Burger, M; Donald, P; Fertig, G; Schoeman, J; Springer, P; van Rensburg, AJ; van Zyl, F; Wait, J, 2002) |
"Noncommunicating hydrocephalus (37 children), as determined by air encephalography, was treated by ventriculoperitoneal (VP) shunting and communicating hydrocephalus (181 children), by means of daily acetazolamide and frusemide." | 1.31 | Serial lumbar CSF presure measurements and cranial computed tomographic findings in childhood tuberculous meningitits. ( Donald, PR; Laubscher, JA; Schoeman, JF, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schoeman, J | 2 |
Wait, J | 2 |
Burger, M | 1 |
van Zyl, F | 1 |
Fertig, G | 1 |
van Rensburg, AJ | 1 |
Springer, P | 1 |
Donald, P | 2 |
Schoeman, JF | 1 |
Laubscher, JA | 1 |
Donald, PR | 1 |
van Zyl, L | 1 |
Keet, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized Double Blind Placebo Controlled Trial of Adjunctive Dexamethasone for the Treatment of HIV-infected Adults With Tuberculous Meningitis[NCT03092817] | Phase 3 | 520 participants (Actual) | Interventional | 2017-05-25 | Active, not recruiting | ||
A Randomized Double Blind Placebo Controlled Non-inferiority Trial of Adjunctive Dexamethasone for the Treatment of HIV-uninfected Adults With Tuberculous Meningitis Stratified by Leukotriene A4 Hydrolase Genotype[NCT03100786] | Phase 3 | 640 participants (Anticipated) | Interventional | 2018-02-08 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for furosemide and Tuberculosis, Meningeal
Article | Year |
---|---|
Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome.
Topics: Acetazolamide; Antitubercular Agents; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Child, | 1991 |
Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome.
Topics: Acetazolamide; Antitubercular Agents; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Child, | 1991 |
Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome.
Topics: Acetazolamide; Antitubercular Agents; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Child, | 1991 |
Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome.
Topics: Acetazolamide; Antitubercular Agents; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Child, | 1991 |
2 other studies available for furosemide and Tuberculosis, Meningeal
Article | Year |
---|---|
Long-term follow up of childhood tuberculous meningitis.
Topics: Acetazolamide; Anti-Inflammatory Agents; Antitubercular Agents; Brain; Child; Cognition Disorders; D | 2002 |
Serial lumbar CSF presure measurements and cranial computed tomographic findings in childhood tuberculous meningitits.
Topics: Acetazolamide; Antitubercular Agents; Cerebrospinal Fluid Pressure; Child; Combined Modality Therapy | 2000 |